Immersive Mixed Reality Simulation to Evoke Empathy (Empathy)

January 17, 2026 updated by: Thomas Caruso, Stanford University
This is a quantifiable study evaluating the ability of a mixed reality (MR), immersive simulation experience to evoke empathy in anesthesiology trainees. Quantitative methodologies will be employed using standardized questionnaires including the The Jefferson Scale of Physician Empathy for Health Professions Students, (HP-version). Trainees will assess their preliminary, baseline empathy using the Jefferson Scale and after the simulation and debrief, will reassess empathy scores, once again using the Jefferson Scale. A satisfaction survey to assess simulated patient embodiment as a valuable exercise and contributor to empathy education curriculum.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

81

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94303
        • Lucile Packard Children's Hospital Stanford

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Trainees or personnel working and/or volunteering at Lucile Packard Children's Hospital Stanford / Stanford Health Care facilities
  • 18 years and older

Exclusion Criteria:

  • a history of severe motion sickness
  • currently have nausea
  • have a history of seizures
  • are uncomfortable wearing a ~7 pound weighted vest.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mixed Reality Group
In the MR group, the simulation instructor will explain the scope of the simulation embodiment experience and equip a weighted vest on the participant as they are asked to lay on a hospital patient gurney, seated upright. The participant, who is wearing a weighted vest to simulate an anterior mediastinal mass, will be asked to be seated upright and will view various holograms including vitals monitors, hear hospital related sounds via the headset, and also see additional holographic assets including intravenous polls and a defibrillator as well as experience heat (simulating a fever) from heat lamps. The simulation instructor will play the role of a physician who is using good communication skills based on the Calgary-Cambridge Guide to review a scripted consent for a high risk biopsy under sedation that may require life saving interventions such as extracorporeal membranous oxygenation (ECMO).

Mixed Reality simulation of medical crisis scenarios.

MR headset - a device that the participants will wear over their head and eyes and will add holographic elements to a live view of workplace training scenario

Active Comparator: Control
In the control group, there will be no headset, no heat lamps, and no weighted vest and the participant will rely on their imagination to embody the teenager while lying in the simulation room bed while being consented for the same procedure as the MR group.
Tradition simulation of medical crisis scenarios.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in self-reported empathy from before and after the simulation
Time Frame: baseline, immediately after the intervention
Measured with Jefferson Scale of Physician Empathy for physicians and other practicing health professionals (HP-Version). The survey contains 20 item with 7-point scale, 1 indicates strongly disagree and 7 indicates strongly agree (a higher number on the scale indicates more agreement).
baseline, immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the CHARM system's usability
Time Frame: immediately after simulation
Measured by System Usability Scale (SUS). The scale has 10 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
immediately after simulation
Evaluation of the CHARM system's ergonomics
Time Frame: immediately after simulation
Measured by the ISO Ergonomic scale. The scale has 6 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
immediately after simulation
Satisfaction of Design Features of the Simulation
Time Frame: immediately after the intervention

Measured by Simulation Design Scale. The simulation design scale consists of 20 items in total. In the first stage, in order to evaluate whether the items used in the simulation method were given in the best way for the participant, they were expressed as strongly disagree, disagree, undecided, agree, strongly agree. The survey contains 20 item with 5-point scale, 1 indicates strongly disagree and 5 indicates strongly agree (a higher number on the scale indicates more agreement).

In the second stage, there are statements that will determine the level of importance of the scale items for the participant, not important, partially important, undecided, important, very important. The survey contains 20 item with 5-point scale, 1 indicates not important and 5 indicates very important (a higher number on the scale indicates more important).

In the evaluation phase, the scale score is calculated by dividing the total and the total of the sub-dimensions by the number of items.

immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 24, 2025

Primary Completion (Actual)

October 8, 2025

Study Completion (Actual)

October 8, 2025

Study Registration Dates

First Submitted

April 1, 2024

First Submitted That Met QC Criteria

April 1, 2024

First Posted (Actual)

April 8, 2024

Study Record Updates

Last Update Posted (Actual)

January 21, 2026

Last Update Submitted That Met QC Criteria

January 17, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 75021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Educational Problems

Clinical Trials on Mixed Reality (MR)

Subscribe